nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Fluorouracil—urinary bladder cancer	0.19	0.645	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—urinary bladder cancer	0.105	0.355	CbGbCtD
Gadobenate Dimeglumine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000409	0.000581	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—urinary bladder cancer	0.000407	0.000577	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000407	0.000577	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Gemcitabine—urinary bladder cancer	0.000406	0.000575	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—urinary bladder cancer	0.000404	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000402	0.00057	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Gemcitabine—urinary bladder cancer	0.0004	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Thiotepa—urinary bladder cancer	0.000399	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000399	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000398	0.000564	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000397	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000395	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Fluorouracil—urinary bladder cancer	0.000393	0.000558	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000393	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—urinary bladder cancer	0.000393	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—urinary bladder cancer	0.000392	0.000556	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000388	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—urinary bladder cancer	0.000388	0.00055	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000387	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—urinary bladder cancer	0.000386	0.000547	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—urinary bladder cancer	0.000383	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—urinary bladder cancer	0.000382	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—urinary bladder cancer	0.000382	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—urinary bladder cancer	0.000382	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000382	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000382	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—urinary bladder cancer	0.00038	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00038	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—urinary bladder cancer	0.000379	0.000538	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000379	0.000538	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cisplatin—urinary bladder cancer	0.000378	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000378	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—urinary bladder cancer	0.000376	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000376	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000375	0.000532	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—urinary bladder cancer	0.000374	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000374	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000373	0.00053	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—urinary bladder cancer	0.000369	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000368	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Fluorouracil—urinary bladder cancer	0.000368	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—urinary bladder cancer	0.000367	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000367	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—urinary bladder cancer	0.000365	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00036	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Gemcitabine—urinary bladder cancer	0.000359	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000359	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—urinary bladder cancer	0.000357	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Rash—Gemcitabine—urinary bladder cancer	0.000356	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000356	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—urinary bladder cancer	0.000356	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000356	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—urinary bladder cancer	0.000355	0.000504	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—urinary bladder cancer	0.000354	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—urinary bladder cancer	0.000354	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gemcitabine—urinary bladder cancer	0.000354	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—urinary bladder cancer	0.000353	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000353	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—urinary bladder cancer	0.000353	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000353	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000351	0.000497	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—urinary bladder cancer	0.00035	0.000497	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00035	0.000497	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—urinary bladder cancer	0.000348	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000348	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000347	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000347	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—urinary bladder cancer	0.000346	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000346	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—urinary bladder cancer	0.000346	0.00049	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000345	0.00049	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000344	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000343	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—urinary bladder cancer	0.000343	0.000486	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—urinary bladder cancer	0.000342	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—urinary bladder cancer	0.000341	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—urinary bladder cancer	0.00034	0.000483	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—urinary bladder cancer	0.00034	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gemcitabine—urinary bladder cancer	0.000336	0.000476	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—urinary bladder cancer	0.000335	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—urinary bladder cancer	0.000334	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cisplatin—urinary bladder cancer	0.000332	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—urinary bladder cancer	0.000332	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—urinary bladder cancer	0.000332	0.00047	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—urinary bladder cancer	0.000332	0.00047	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—urinary bladder cancer	0.00033	0.000469	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—urinary bladder cancer	0.00033	0.000468	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000329	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000329	0.000466	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000329	0.000466	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—urinary bladder cancer	0.000327	0.000465	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—urinary bladder cancer	0.000327	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000327	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000325	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—urinary bladder cancer	0.000321	0.000455	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—urinary bladder cancer	0.00032	0.000454	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—urinary bladder cancer	0.000319	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—urinary bladder cancer	0.000319	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000319	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000318	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000318	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—urinary bladder cancer	0.000317	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—urinary bladder cancer	0.000316	0.000449	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000315	0.000447	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—urinary bladder cancer	0.000313	0.000444	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—urinary bladder cancer	0.000309	0.000439	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000309	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000308	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—urinary bladder cancer	0.000307	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000307	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—urinary bladder cancer	0.000307	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—urinary bladder cancer	0.000306	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—urinary bladder cancer	0.000304	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—urinary bladder cancer	0.000304	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—urinary bladder cancer	0.000302	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—urinary bladder cancer	0.000302	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—urinary bladder cancer	0.000302	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—urinary bladder cancer	0.000302	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.0003	0.000426	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.0003	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—urinary bladder cancer	0.000299	0.000424	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—urinary bladder cancer	0.000298	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—urinary bladder cancer	0.000297	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—urinary bladder cancer	0.000297	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—urinary bladder cancer	0.000297	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000295	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—urinary bladder cancer	0.000293	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—urinary bladder cancer	0.000292	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000291	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—urinary bladder cancer	0.000289	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000289	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—urinary bladder cancer	0.000287	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—urinary bladder cancer	0.000287	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—urinary bladder cancer	0.000286	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000285	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000284	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—urinary bladder cancer	0.000284	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—urinary bladder cancer	0.000282	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—urinary bladder cancer	0.000282	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—urinary bladder cancer	0.000282	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—urinary bladder cancer	0.000281	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—urinary bladder cancer	0.000281	0.000398	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00028	0.000398	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000279	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—urinary bladder cancer	0.000279	0.000396	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—urinary bladder cancer	0.000277	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—urinary bladder cancer	0.000276	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—urinary bladder cancer	0.000275	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000275	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—urinary bladder cancer	0.000273	0.000387	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—urinary bladder cancer	0.000271	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000271	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—urinary bladder cancer	0.00027	0.000383	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00027	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—urinary bladder cancer	0.000269	0.000381	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—urinary bladder cancer	0.000268	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—urinary bladder cancer	0.000266	0.000378	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000265	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—urinary bladder cancer	0.000265	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—urinary bladder cancer	0.000264	0.000375	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000263	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—urinary bladder cancer	0.000263	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000262	0.000371	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000261	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—urinary bladder cancer	0.000261	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—urinary bladder cancer	0.000261	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—urinary bladder cancer	0.00026	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—urinary bladder cancer	0.00026	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000259	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—urinary bladder cancer	0.000258	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000258	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—urinary bladder cancer	0.000257	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000255	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000254	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—urinary bladder cancer	0.000253	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—urinary bladder cancer	0.000252	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00025	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00025	0.000354	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—urinary bladder cancer	0.000249	0.000354	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—urinary bladder cancer	0.000249	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—urinary bladder cancer	0.000247	0.000351	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000246	0.00035	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—urinary bladder cancer	0.000246	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000245	0.000348	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000244	0.000347	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000243	0.000345	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000243	0.000345	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000242	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000241	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—urinary bladder cancer	0.000241	0.000341	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000238	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000238	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000236	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—urinary bladder cancer	0.000234	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000234	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—urinary bladder cancer	0.000233	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—urinary bladder cancer	0.000231	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—urinary bladder cancer	0.000231	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—urinary bladder cancer	0.00023	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000229	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000229	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000228	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000225	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000223	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000223	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—urinary bladder cancer	0.000223	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000221	0.000314	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00022	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000216	0.000307	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—urinary bladder cancer	0.000216	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—urinary bladder cancer	0.000215	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—urinary bladder cancer	0.000214	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—urinary bladder cancer	0.000214	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000214	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000214	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000213	0.000302	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—urinary bladder cancer	0.000207	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000206	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000205	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—urinary bladder cancer	0.000205	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000199	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—urinary bladder cancer	0.000199	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000198	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000198	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000198	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—urinary bladder cancer	0.000194	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—urinary bladder cancer	0.000191	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—urinary bladder cancer	0.000191	0.000271	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000185	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000184	0.000262	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—urinary bladder cancer	0.000184	0.000261	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—urinary bladder cancer	0.000182	0.000259	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—urinary bladder cancer	0.000182	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—urinary bladder cancer	0.000181	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—urinary bladder cancer	0.00018	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—urinary bladder cancer	0.000179	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—urinary bladder cancer	0.000177	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—urinary bladder cancer	0.000172	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—urinary bladder cancer	0.000172	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000171	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—urinary bladder cancer	0.000171	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—urinary bladder cancer	0.00017	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—urinary bladder cancer	0.000169	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—urinary bladder cancer	0.000166	0.000235	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—urinary bladder cancer	0.000161	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—urinary bladder cancer	0.000159	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—urinary bladder cancer	0.000158	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000158	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—urinary bladder cancer	0.000157	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—urinary bladder cancer	0.000149	0.000211	CcSEcCtD
